Deepcure

​DeepCure is a Boston-based biotechnology company specializing in AI-driven drug discovery for small molecule therapeutics. Founded in 2018, DeepCure's platform integrates advanced artificial intelligence, physics-based tools, and automated chemical synthesis to identify novel compounds targeting immune and inflammatory diseases. The company's pipeline includes preclinical assets for conditions such as rheumatoid arthritis, hidradenitis suppurativa, and asthma. DeepCure primarily serves pharmaceutical and biotechnology sectors seeking innovative approaches to drug development